CCNE1 and Parkinson disease: By integrating two‐sample MR, mediation analysis, and transcriptomic data, we confirm that genetically determined high expression of CCNE1 significantly lowers PD risk (β = −0.362, p = 0.032), with this effect primarily mediated by PARP16 (mediated proportion: 44.17%).